BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22739228)

  • 21. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
    Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
    Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
    Stahl RA; Hoxha E; Helmchen U
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
    Kim Y; Yoon HE; Chung BH; Choi BS; Park CW; Yang CW; Kim YS; Hong YA; Kim SY; Chang YK; Hwang HS
    Korean J Intern Med; 2019 Sep; 34(5):1091-1099. PubMed ID: 31408925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
    Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
    Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of idiopathic membranous nephropathy.
    Ehrenreich T; Porush JG; Churg J; Garfinkel L; Glabman S; Goldstein MH; Grishman E; Yunis SL
    N Engl J Med; 1976 Sep; 295(14):741-6. PubMed ID: 958260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.
    Javaugue V; Karras A; Glowacki F; McGregor B; Lacombe C; Goujon JM; Ragot S; Aucouturier P; Touchard G; Bridoux F
    Am J Kidney Dis; 2013 Oct; 62(4):679-90. PubMed ID: 23759297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Membranous kidney diseases in adults].
    Sobarzo Toro M; Vilches A
    Medicina (B Aires); 2004; 64(1):59-65. PubMed ID: 15034960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membranous nephropathy related to hepatitis B virus in adults.
    Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
    N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early prediction of treatment outcome in idiopathic membranous nephropathy.
    O'Callaghan CA; Cameron JS; Sacks SH
    QJM; 1995 Dec; 88(12):889-94. PubMed ID: 8593548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.